Table 4 Fisher’s exact test to evaluate the association between ABCC1 and other clinical factors
Covariate | Score | ABCC1 Negative | ABCC1 Positive | Fisher's ExactTest (2-Tail) |
|---|---|---|---|---|
ABCG2 | Negative | 39 (79.6%) | 10 (20.4%) | .5227 |
Positive | 22 (88%) | 3 (12%) | ||
Chemotherapy | ABVD (R-ABVD & MOPP/ABVD) | 20 (76.9%) | 6 (23.1%) | .8762 |
CVPP/ABDIC | 15 (83.3%) | 3 (16.7%) | ||
NOVP | 31 (81.6%) | 7 (18.4%) | ||
Radiotherapy | No | 17 (89.5%) | 2 (10.5%) | .3329 |
Yes | 45 (77.6%) | 13 (22.4%) | ||
Bone marrow disease | No | 62 (79.5%) | 16 (20.5%) | 1.000 |
Yes | 3 (100%) | 0 (0%) | ||
Stage IV disease | No | 53 (80.3%) | 13 (19.7%) | 1.000 |
Yes | 13 (81.3%) | 3 (18.8%) | ||
Hemoglobin | ≥105 g/l | 58 (79.5%) | 15 (20.5%) | .6811 |
< 105 g/l | 8 (88.9%) | 1 (11.1%) | ||
Albumin | ≥ 40 g/l | 35 (79.5%) | 9 (20.5%) | 1.000 |
< 40 g/l | 23 (82.1%) | 5 (17.9%) | ||
WBC | <15,000 per mm3 | 62 (79.5%) | 16 (20.5%) | .5814 |
≥15,000 per mm3 | 4 (100%) | 0 (0%) | ||
Lymphocytes | < 600 per mm3 | 52 (80%) | 13 (20%) | 1.000 |
≥ 600 per mm3 | 11 (78.6%) | 3 (21.4%) | ||
Age ≥45 | < 45 years | 51 (78.5%) | 14 (21.5%) | .5028 |
≥ 45 years | 15 (88.2%) | 2 (11.8%) | ||
Sex | Female | 26 (76.5%) | 8 (23.5%) | .5731 |
Male | 40 (83.3%) | 8 (16.7%) | ||
IPS | <3 | 51 (77.3%) | 15 (22.7%) | .2811 |
≥3 | 14 (93.3%) | 1 (6.7%) |